Results

Total Results: 1,361 records

Showing results for "clinical practice guideline".
Users also searched for: clinical practice guidelines

1341. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
      January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…

1342. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
      January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…

1343. 08 Functional Limitations Potential High Impact 2012-12-10 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
      January 01, 2012 - AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 08: Functional Limitations and Disability Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov …

1344. Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
      August 01, 2016 - Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review Context and Purpose of Review The value of omega 3 fatty acids (n-3 FA) intake to improve cardiovascular outcomes and risk factors remains controversial. This review updates prior Evidence Reports on this topic. The n-3 FA under review in…

1345. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
      August 24, 2012 - Comparative Effectiveness Review Disposition of Comments Report Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1235 Published Online: August 24, 2012 Comparative Effectiveness Research Review Disposition of Comments Report Research …

1346. Glaucoma-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
      April 01, 2012 - 1 Comparative Effectiveness Review Number 60 Treatment for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment and blindness both in the United States and worldwide. It is estimated to affect 60.5 million people worldwide.1 Glaucoma is defined as…

1347. Glaucoma-Screening Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
      April 01, 2012 - 1 Comparative Effectiveness Review Number 59 Screening for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment and blindness and affects approximately 60.5 million people worldwide.1,2 Although glaucoma may be characterized by optic nerve damage, …

1348. Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities Appendices (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_appendixes.pdf
      May 23, 2005 - Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities Appendices Appendix A. Literature Search Strategies Literature Search Strategies Electronic Database Searches The following databases have been searched for relevant information: ClinicalTrials.gov (through April 2005) Cochrane Data…

1349. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
      October 01, 2009 - Layout 1 Background Nearly 2,400 Americans die of cardiovascular disease each day, an average of one death every 36 seconds. Cardiovascular disease claims more lives each year than cancer, chronic lower respiratory diseases, accidents, and diabetes mellitus combined. An estimated 79,400,000 American adults (one in …

1350. Disposition of Comments for Technical Brief 21, Management Strategies To Reduce Psychiatric Readmissions (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/psychiatric-readmissions_disposition-comments.pdf
      May 21, 2015 - Disposition of Comments for Technical Brief 21, Management Strategies To Reduce Psychiatric Readmissions Technical Brief Disposition of Comments Report Research Review Title: Management Strategies To Reduce Psychiatric Readmissions Draft review available for public comment from December 1, 2014 to Dece…

1351. About the Evidence Synthesis Process | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/about/epc/evidence-synthesis

1352. Machine-Learning-Tools-Appendix-C (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/machine-learning-tools-appendix-c.xlsx
      January 01, 2024 - Search screening tools PMID Authors Title Pubyear Tool_name Environment Access Model Model_type ESP_Task Specific_ESP_task Training Inputs Outputs Notes Purported_use Reference_standard Manual_sensitivity Manual_precision Positivity_threshold Stopping_rule Nruns datasets Summary_measure Burden Burden_dispersion Sensit…

1353. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
      October 01, 2010 - Layout 1 Background Cystic fibrosis (CF) is the second most common life-shortening, childhood-onset genetic disease in the United States, affecting approximately 30,000 people in the Nation. The gene responsible for CF encodes the cystic fibrosis transmembrane regulator (CFTR) protein, which regulates sodium and chl…

1354. Total Worker Health® (TWH) (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
      April 01, 2016 - Total Worker Health® (TWH) 1 Comparative Effectiveness Review Number 175 Total Worker Health® Effective Health Care Program Executive Summary Background The American worksite has been a venue for both health protection and health promotion programs. Health protection programs are interventions aimed specifi…

1355. Covariate Selection for Observational Comparative Effectiveness Research
      effectivehealthcare.ahrq.gov/sites/default/files/covariate-selection-chapter-7.pptx
      January 01, 2013 - Covariate Selection for Observational Comparative Effectiveness Research Covariate Selection for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Covariate Selection for Observational Comparative Effectiveness Research This slide set is b…

1356. Comparative Effectiveness of Nonoperative and Operative Treatments for Rotator Cuff Tears | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/rotator-cuff-tear/research

1357. Rapid Evidence Product: Misuse of ADHD Prescription Stimulants in Adults (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
      July 01, 2025 - Rapid Evidence Product: Misuse of ADHD Prescription Stimulants in Adults Rapid Evidence Product June 2025 Misuse of ADHD Prescription Stimulants in Adults Background and Purpose The U.S. Food and Drug Administration (FDA) commissioned a rapid review, through the Agency for Healthcare Research an…

1358. Medicare-Medication-Use Research (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
      April 01, 2014 - Medication use among Medicare beneficiaries with medical and psychiatric conditions, 2009-2011 Medication Use in Medicare Data Points #19 Within the Medicare population, the major- ity of beneficiaries who have a psychiatric diagnosis also have one or more medical diagnoses. Use of multiple medications is common …

1359. Cell-Free-Dna-Appendix-C-Prepub-Final (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-appendix-c-prepub-final.xlsx
      January 01, 2025 - Table C-1. KQ 3,4, 5 Char. Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5 First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (years) Eligible Minimum Age Actual Minimum Age …

1360. Cell-Free-Dna-Final-App-C (xls file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
      January 01, 2025 - Table C-1. KQ 3,4, 5 Char. Table C-1 Characteristics of included studies KQ 3, KQ 4, and KQ 5 First Author Last Name Year of Publication Citation Study Cohort Name Study Registration Number Related Publications Study Funder Country Study Design Population Narrative Age (Years) Eligible Minimum Age Actual Minimum Age …